We have located links that may give you full text access.
[Effects of sevoflurane-induced and anoxia-induced preconditioning on HSP70 expression in neonatal rat cardiomyocytes].
Hunan Yi Ke da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University 2003 April
OBJECTIVE: To explore the effects of sevoflurane-preconditioning and anoxia-preconditioning on HSP70 expression in neonatal rat cardiomyocytes.
METHODS: The second generation of primary cultured cardiomyocytes was randomly divided into 4 groups: normal control (Group C), anoxia/reoxygenation group (Group A/R), anoxia-preconditioning group (Group IP), and sevoflurane-preconditioning group (Group S); In each group, the cardiomyocytes were subjected to anoxia (2 h) followed by reoxygenation (48 h). The immunohistochemistry was used to determine the expression of HSP70 protein in neonatal rat cardiomyocytes at 0, 1, 12, 24, 36 and 48 h after reoxygenation respectively.
RESULTS: At each point of time studying reoxygenation, the expression level of HSP70 in Group S and Group IP was significantly higher than that in Group A/R and Group C (P < 0.01). The HSP70 expression level in Group A/R was slightly higher than that in Group C. No significant difference was found in HSP70 expression between Group IP and Group S (P > 0.05). The expression level of HSP70 protein in both Group S and Group IP increased concomitantly with the reoxygenation time from 1 h after reoxygenation, and reached the peak at 24 h of reoxygenation (P < 0.01).
CONCLUSION: sevoflurane-preconditioning and anoxia preconditioning can induce the high level expression of HSP70 in the neonatal rat cardiomyocytes with the phase of protection delayed. It is suggested that HSP70 may be involved in the process of the delayed phase of protection induced by sevoflurane-preconditioning and anoxia-preconditioning respectively.
METHODS: The second generation of primary cultured cardiomyocytes was randomly divided into 4 groups: normal control (Group C), anoxia/reoxygenation group (Group A/R), anoxia-preconditioning group (Group IP), and sevoflurane-preconditioning group (Group S); In each group, the cardiomyocytes were subjected to anoxia (2 h) followed by reoxygenation (48 h). The immunohistochemistry was used to determine the expression of HSP70 protein in neonatal rat cardiomyocytes at 0, 1, 12, 24, 36 and 48 h after reoxygenation respectively.
RESULTS: At each point of time studying reoxygenation, the expression level of HSP70 in Group S and Group IP was significantly higher than that in Group A/R and Group C (P < 0.01). The HSP70 expression level in Group A/R was slightly higher than that in Group C. No significant difference was found in HSP70 expression between Group IP and Group S (P > 0.05). The expression level of HSP70 protein in both Group S and Group IP increased concomitantly with the reoxygenation time from 1 h after reoxygenation, and reached the peak at 24 h of reoxygenation (P < 0.01).
CONCLUSION: sevoflurane-preconditioning and anoxia preconditioning can induce the high level expression of HSP70 in the neonatal rat cardiomyocytes with the phase of protection delayed. It is suggested that HSP70 may be involved in the process of the delayed phase of protection induced by sevoflurane-preconditioning and anoxia-preconditioning respectively.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app